| Nov 18 |
Biotech Stock Attempts To End Losing Streak, Lands Back in Buy Zone
|
| Nov 18 |
Rhythm Pharmaceuticals Announces Five Presentations at ESPE 2024, including New Real-world Data in Pediatric Patients with Acquired or Congenital Hypothalamic Obesity Treated with Setmelanotide
|
| Nov 14 |
Rhythm releases positive Imcivree data for younger age group
|
| Nov 13 |
Rhythm Pharmaceuticals Announces Publication of Results from Phase 3 Study of Setmelanotide in Patients Between 2 and 5 Years Old in The Lancet Diabetes & Endocrinology
|
| Nov 13 |
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
|
| Nov 12 |
High Growth Tech Stocks Featuring Three Prominent US Companies
|
| Nov 7 |
Rhythm Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
|
| Nov 7 |
Rhythm Pharmaceuticals Inc (RYTM) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...
|
| Nov 6 |
Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
|
| Nov 6 |
Rhythm Pharmaceuticals, Inc. (RYTM) Q3 2024 Earnings Call Transcript
|
